$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Nano-niosomes as nanoscale drug delivery systems: An illustrated review

Journal of controlled release : official journal of the Controlled Release Society, v.185, 2014년, pp.22 - 36  

Moghassemi, S. ,  Hadjizadeh, A.

Abstract AI-Helper 아이콘AI-Helper

The field of nanochemistry research has shown a great progress in the developing of novel nanocarriers as potential drug delivery systems. Niosome is a class of molecular cluster formed by self-association of non-ionic surfactants in an aqueous phase. The unique structure of niosome presents an effe...

주제어

참고문헌 (91)

  1. Int. Res. J. Pharm. Rajiv 2 91 2011 Nanoburrs: a novel approach in the treatment of cardiovascular disease 

  2. Nanomedicine J. Pardakhty 1 1 2013 Nano-niosomes in drug, vaccine and gene delivery: a rapid overview 

  3. Steed 2007 Core Concepts in Supramolecular Chemistry and Nanochemistry 

  4. Int. J. Pharm. Waddad 456 446 2013 10.1016/j.ijpharm.2013.08.040 Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants 

  5. J. Pharm. Sci. Leroux 84 1387 1995 10.1002/jps.2600841202 Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice 

  6. J. Control. Release Minghuang Hong 133 2009 96 2009 10.1016/j.jconrel.2008.09.005 Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin 

  7. Int. J. Pharm. Vyas 296 2005 80 2005 10.1016/j.ijpharm.2005.02.016 Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B 

  8. IJPSR Marwa 4 5 2013 Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations 

  9. Adv. Powder Technol. Gurrapu RJ 1 2011 Improved oral delivery of valsartan from maltodextrin based proniosome powders 

  10. Int. J. Pharm. Hamdy Abdelkader 432 1 2012 10.1016/j.ijpharm.2012.04.063 Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models 

  11. Abdelkader 100 5 1833 2011 Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery 

  12. J. Appl. Pharm. Sci. Rajeswari 01 12 2011 Non invasive insulins: advanced insulin therapy over this decade 

  13. Int. J. Pharm. Elhissi 444 193 2013 10.1016/j.ijpharm.2012.12.040 Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology 

  14. J. Control. Release Carlotta Marianecci 147 1 127 2010 10.1016/j.jconrel.2010.06.022 Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblast 

  15. Eur. J. Immunol. Walker 26 1664 1996 10.1002/eji.1830260740 Lipid vesicle-entrapped influenza A antigen modulates the influenza A-specific human antibody response in immune reconstituted SCID-human mice 

  16. Int. J. Pharm. Ammar 405 142 2011 10.1016/j.ijpharm.2010.11.003 Proniosomes as a carrier system for transdermal delivery of tenoxicam 

  17. European journal of pharmaceutics and biopharmaceutics El-Laithy 77 43 2011 10.1016/j.ejpb.2010.10.011 Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies 

  18. Int. J. Pharm. Manosroi 392 304 2010 10.1016/j.ijpharm.2010.03.064 Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes 

  19. Int. J. Pharm. Varaporn Buraphacheep Junyaprasert 423 303 2012 10.1016/j.ijpharm.2011.11.032 Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid 

  20. Int. J. Pharm. Balakrishnan 244 2002 73 2009 Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery 

  21. J. Pharm. Pharm. Sci. Aliasgar Shahiwala 5 3 220 2002 Studies in topical application of niosomally entrapped Nimesulide 

  22. Int. J. Pharm. Fang 215 2001 91 2001 10.1016/S0378-5173(00)00669-4 In vitro skin permeation of estradiol from various proniosome formulations 

  23. Int. J. Drug Deliv. Shilpa 3 14 2011 10.5138/ijdd.2010.0975.0215.03050 Niosomes as vesicular carriers for delivery of proteins and biologicals 

  24. Physicochem. Eng. Asp. Tianqing Liu 293 255 2007 10.1016/j.colsurfa.2006.07.053 Structure behaviors of hemoglobin in PEG 6000/Tween 80/Span 80/H2O niosome system 

  25. Physicochem. Eng. Asp. Wei Hua 302 377 2007 10.1016/j.colsurfa.2007.02.068 Preparation and properties of highly stable innocuous niosome in Span 80/PEG 400/H2O system 

  26. Langmuir Liu 21 11034 2005 10.1021/la051868b Preparation of a highly stable niosome and its hydrotrope-solubilization action to drugs 

  27. Bioconjug. Chem. Pouyani 5 4 339 1994 10.1021/bc00028a010 Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials 

  28. J. Control. Release Prestwich 53 1-3 93 1998 10.1016/S0168-3659(97)00242-3 Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives 

  29. J. Control. Release Mizrahy 156 231 2011 10.1016/j.jconrel.2011.06.031 Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response 

  30. J. Control. Release Marianecci 147 2010 127 2010 10.1016/j.jconrel.2010.06.022 Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblast 

  31. Annual Reports Section" C"(Physical Chemistry) Schramm 99 3 2003 10.1039/B208499F 2Surfactants and their applications 

  32. Malmsten 2002 Surfactants and Polymers in Drug Delivery 

  33. Acta Pharm. Sin. B Kumar Gannu 2011 Nonionic surfactant vesicular systems for effective drug delivery - an overview 

  34. Int. J. Pharm. Sci. Nanotechnol. Biswal 1 1 2008 Vesicles of non-ionic surfactants (niosomes) and drug delivery potential 

  35. Int. J. Pharm. Uchegbu 172 33 1998 10.1016/S0378-5173(98)00169-0 Non-ionic surfactant based vesicles (niosomes) in drug delivery 

  36. Int. J. Pharm. Pardakhty 328 2007 130 2006 In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin 

  37. Bouwstra 191 1996 Colloidal Drug Delivery Systems Niosomes 

  38. Int. J. Pharm. Fang 219 1-2 61 2001 10.1016/S0378-5173(01)00627-5 Effect of liposomes and niosomes on skin permeation of enoxacin 

  39. Indian J. Pharm. Sci. Agarwal 66 1 121 2004 Effect of cholesterol content and surfactant HLB on vesicle properties of niosomes 

  40. J. Chem. Pharm. Res. Verma 2 2 496 2010 Nanoparticle vesicular systems: a versatile tool for drug delivery 

  41. Int. J. Pharm. Guinedi 306 71 2005 10.1016/j.ijpharm.2005.09.023 Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide 

  42. IJPSR Tarekegn 1 9 1 2010 Niosomes in targeted drug delivery: some recent advances 

  43. Int. J. Pharm. Carafa 231 21 2002 10.1016/S0378-5173(01)00828-6 Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies 

  44. Int. J. Pharm. Kaur 269 1 2004 10.1016/j.ijpharm.2003.09.016 Vesicular systems in ocular drug delivery: an overview 

  45. Int. J. Pharm. Hao 403 245 2011 10.1016/j.ijpharm.2010.10.027 Entrapment and release difference resulting from hydrogen bonding interactions in niosome 

  46. Int. J. Pharm. Muzzalupo 458 1 224 2013 10.1016/j.ijpharm.2013.09.011 Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological properties 

  47. Langmuir Tavano 29 12638 2013 10.1021/la4021383 Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy 

  48. Colloids Surf. B: Biointerfaces Tavano 114 82 2014 10.1016/j.colsurfb.2013.09.058 Co-encapsulation of antioxidants into niosomal carriers: gastrointestinal release studies for nutraceutical applications 

  49. J. Pharm. Sci. Arunothayanun 88 34 1999 10.1021/js980286u Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes 

  50. Br. J. Cancer Kerr 58 432 1988 10.1038/bjc.1988.235 Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft 

  51. Cable 1989 Anexamination of the Effects of Surface Modifications on the Physico-chemical and Biological Properties of Non-ionic Surfactant Vesicles 

  52. Pharm. Res. Dufes 17 1250 2000 10.1023/A:1026422915326 Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting 

  53. J. Pharm. Res. Health Care Sharma 11 142 2009 Niosomal oral suspension of fluconazole: formulation and in vitro evaluation 

  54. J. Microencapsul. Jain 12 401 1995 10.3109/02652049509087252 Preparation and characterization of niosomes containing Rifampicin for lung targeting 

  55. Kirby 19 1984 In Liposome Technology A simple procedure for preparing liposomes capable of high encapsulation effeciency under mild conditions 

  56. Int. J. Pharm. Mokhtar 361 2008 104 2008 10.1016/j.ijpharm.2008.05.031 Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes 

  57. Immunomethods Weiner 4 201 1994 10.1006/immu.1994.1021 Liposomes for protein delivery: selecting manufacture and development processes 

  58. Int. J. Pharm. Bendas 458 287 2013 10.1016/j.ijpharm.2013.10.042 Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus 

  59. Nanomedicine Alam 9 247 2013 10.1016/j.nano.2012.07.004 Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis 

  60. J. Biotechnol. Mortazavi 129 4 604 2007 10.1016/j.jbiotec.2007.02.005 Preparation of liposomal gene therapy vectors by a scalable method without using volatile solvents or detergents 

  61. Pharmazie Mozafari 62 205 2007 Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents 

  62. Mozafari 101 2005 Nanoliposomes: From Fundamentals to Recent Developments Construction of a gene deliveryvector using anionic liposomes 

  63. J. Liposome Res. Mozafari 15 93 2005 10.1081/LPR-64965 Areviewof scanning probe microscopy investigations of liposome-DNA complexes 

  64. Cell. Mol. Biol. Lett. Mozafari 7 923 2002 Construction of stable anionic liposome-plasmid particles using the heating method. A preliminary investigation 

  65. Chem. Phys. Lipids Hope 40 89 1986 10.1016/0009-3084(86)90065-4 Generation of multilamellar and unilamellar phospholipid vesicles 

  66. J. Control. Release Zucker 139 1 73 2009 10.1016/j.jconrel.2009.05.036 Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties 

  67. Curr. Opin. Colloid Interface Sci. Barenholz 6 66 2001 10.1016/S1359-0294(00)00090-X Liposome application: problems and prospects 

  68. Biochim. Biophys. Acta Haran 1151 201 1993 10.1016/0005-2736(93)90105-9 Transmembrane ammonium sulphate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases 

  69. Int. J. Biopharm. Tangri 2 47 2011 Niosomes: formulation and evaluation 

  70. J. Pharm. Sci. Zerrin Sezgin Bayindir 99 4 2010 Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery 

  71. Drummond 149 2007 Intraliposomal Trapping Agents for Improving In Vivo Liposomal Drug Formulation Stability 

  72. Int. J. PharmTech Res. Mohamed Firthouse 3 2011 Formulation and evaluation of miconazole niosomes 

  73. Biomaterials Chen 32 9826 2011 10.1016/j.biomaterials.2011.08.087 A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery 

  74. Pharm. Res. Thompson 28 886 2011 10.1007/s11095-010-0345-x Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells - towards oral insulin 

  75. Int. J. Pharm. Woitiski 412 123 2011 10.1016/j.ijpharm.2011.04.003 Facilitated nanoscale delivery of insulin across intestinal membrane models 

  76. J. Control. Release Rekha 135 144 2009 10.1016/j.jconrel.2009.01.011 Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption 

  77. Pharm. Res. Ma 20 1812 2003 10.1023/B:PHAM.0000003379.76417.3e Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles 

  78. Int. J. Pharm. Laouini 415 53 2011 10.1016/j.ijpharm.2011.05.034 Liposome preparation using a hollow fiber membrane contactor - application to spironolactone encapsulation 

  79. Nanomedicine Wang 1 2011 Quantum dots, lighting up the research and development of nanomedicine 

  80. Colloids Surf. A Physicochem. Eng. Asp. Wei Hua 302 1 377 2007 10.1016/j.colsurfa.2007.02.068 Preparation and properties of highly stable innocuous niosome in Span 80/PEG 400/H2O system 

  81. J. Mater. Sci. Mater. Med. Huang 19 607 2007 10.1007/s10856-007-3193-4 PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides 

  82. Colloids Surf. B: Biointerfaces Di 104 200 2013 10.1016/j.colsurfb.2012.10.036 Polysorbate 20 vesicles as oral delivery system: In vitro characterization 

  83. J. Phys. Chem. B Mandal 117 6957 2013 10.1021/jp403724g Modulation of the Photophysical properties of curcumin in nonionic surfactant (Tween-20) forming micelles and niosomes: a comparative study of different microenvironments 

  84. Netter 2006 Atlas of Human Anatomy 

  85. Mescher 2010 Junqueira's Basic Histology 

  86. Hansen 2002 Icon Learning Systems Teterboro Netter's Atlas of Human Physiology 

  87. Rizzo 2001 Instructor's Manual for Delmar's Fundamentals of Anatomy and Physiology: Thomson Learning 

  88. Schmitt 2001 Analysis of Surfactants 

  89. J. Control. Release Puras 174 27 2014 10.1016/j.jconrel.2013.11.004 A novel cationic niosome formulation for gene delivery to the retina 

  90. Eur. J. Pharm. Sci. Murdan 8 177 1999 10.1016/S0928-0987(99)00014-7 Sorbitan monostearate/polysorbate 20 organogels containing niosomes: a delivery vehicle for antigens? 

  91. J. Control. Release Kikuchi 62 269 1999 10.1016/S0168-3659(99)00047-4 Gene delivery using liposome technology 

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로